FDA Submits Proposed Collection of Information for OMB Review Under Paperwork Reduction Act

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance, as required by the Paperwork Reduction Act of 1995, to support the use of symbols on labels and in labeling of in vitro diagnostic devices intended for professional use.